Smart Syringes Market Size, Share & Trends Report

Smart Syringes Market Size, Share & Trends Analysis Report By Therapeutic Category (Auto-Disable Syringes, Active Safety Syringes, Passive Safety syringes), By Application (Drug delivery, Vaccination, Blood Specimen Collection), By End-use, By Region, And Segment Forecasts To 2024

Report ID: 978-1-68038-896-1
Number of Pages: 100
Format: Electronic (PDF)

Historical Data: 2010-2012
Industry: Healthcare

Market segmentation

Smart Syringes Therapeutics Outlook (USD Billion, 2013 - 2024)
- Auto-disable syringes
- Active safety syringes
- Passive safety syringes
Smart Syringes Application Outlook (USD Billion, 2013 - 2024)
- Drug delivery
- Vaccination
- Blood specimen collection
Smart Syringes End-use Outlook (USD Billion, 2013 - 2024)
- Hospitals and HMOs
- Diabetic patients
- Family practices (Physicians)
- Psychiatrists
- Others
Smart Syringes Regional Outlook (USD Billion, 2015 - 2024)
- North America
  - North America Product Outlook by Revenue (USD Billion), 2013 - 2024
    - Auto-disable syringes
    - Active safety syringes
    - Passive safety syringes
  - North America Application Outlook by Revenue (USD Billion), 2013 - 2024
    - Drug delivery
    - Vaccination
    - Blood specimen collection
  - North America End-user Outlook by Revenue (USD Billion), 2013 - 2024
    - Hospitals and HMOs
    - Diabetic patients
    - Family practices (Physicians)
    - Psychiatrists
    - Others
  - The U.S.
    - U.S. Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - U.S. Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - U.S. End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
  - Canada
    - Canada Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - Canada Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - Canada End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
- Europe
  - Europe Product Outlook by Revenue (USD Billion), 2013 - 2024
    - Auto-disable syringes
    - Active safety syringes
    - Passive safety syringes
  - Europe Application Outlook by Revenue (USD Billion), 2013 - 2024
    - Drug delivery
    - Vaccination
    - Blood specimen collection
  - Europe End-user Outlook by Revenue (USD Billion), 2013 - 2024
    - Hospitals and HMOs
    - Diabetic patients
    - Family practices (Physicians)
    - Psychiatrists
    - Others
  - Germany
    - Germany Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - Germany Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - Germany End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
  - UK
    - UK Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - UK Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - UK End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
- Asia Pacific
  - Asia Pacific Product Outlook by Revenue (USD Billion), 2013 - 2024
    - Auto-disable syringes
    - Active safety syringes
    - Passive safety syringes
  - Asia Pacific Application Outlook by Revenue (USD Billion), 2013 - 2024
    - Drug delivery
    - Vaccination
    - Blood specimen collection
  - Asia Pacific End-user Outlook by Revenue (USD Billion), 2013 - 2024
    - Hospitals and HMOs
    - Diabetic patients
    - Family practices (Physicians)
    - Psychiatrists
    - Others
  - Japan
    - Japan Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - Japan Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - Japan End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
  - China
    - China Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - China Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - China End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
- Latin America
  - Latin America Product Outlook by Revenue (USD Billion), 2013 - 2024
    - Auto-disable syringes
    - Active safety syringes
    - Passive safety syringes
  - Latin America Application Outlook by Revenue (USD Billion), 2013 - 2024
    - Drug delivery
    - Vaccination
    - Blood specimen collection
  - Latin America End-user Outlook by Revenue (USD Billion), 2013 - 2024
    - Hospitals and HMOs
    - Diabetic patients
    - Family practices (Physicians)
    - Psychiatrists
    - Others
  - Brazil
    - Brazil Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - Brazil Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - Brazil End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
  - Mexico
    - Mexico Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - Mexico Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - Mexico End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others
- MEA
  - MEA Product Outlook by Revenue (USD Billion), 2013 - 2024
    - Auto-disable syringes
    - Active safety syringes
    - Passive safety syringes
  - MEA Application Outlook by Revenue (USD Billion), 2013 - 2024
    - Drug delivery
    - Vaccination
    - Blood specimen collection
  - MEA End-user Outlook by Revenue (USD Billion), 2013 - 2024
    - Hospitals and HMOs
    - Diabetic patients
    - Family practices (Physicians)
    - Psychiatrists
    - Others
  - South Africa
    - South Africa Product Outlook by Revenue (USD Billion), 2013 - 2024
      - Auto-disable syringes
      - Active safety syringes
      - Passive safety syringes
    - South Africa Application Outlook by Revenue (USD Billion), 2013 - 2024
      - Drug delivery
      - Vaccination
      - Blood specimen collection
    - South Africa End-user Outlook by Revenue (USD Billion), 2013 - 2024
      - Hospitals and HMOs
      - Diabetic patients
      - Family practices (Physicians)
      - Psychiatrists
      - Others

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2013 to 2024
Revenue estimates for treatment up to 2024
Regional market size and forecast for treatment up to 2024
Revenue estimates for gender up to 2024
Regional market size and forecast for gender up to 2024
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.